Singapore conditionally clears laboratory deal
Singapore’s competition watchdog has accepted revised commitments offered by Pathology Asia to clear its purchase and merging of pathology companies Innovative Diagnostics and Quest Laboratories.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.